Stockreport

Why The Narrative Around Castle Biosciences (CSTL) Is Shifting With New Revenue Targets [Yahoo! Finance]

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report
PDF Castle Biosciences is back in focus as some analysts move price targets from the mid $30s to around $52, while at least one fair value view at $48.5 remains unchanged. [Read more]